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Available online 15 January 2014The recent study by Cunningham, Lewis, Curnow,
Glazner, and Massie [1] on the attitudes of respiratory
physicians and clinic coordinators towards cystic fibrosis
(CF) carrier screening drew several unsupported conclusions
because the α level of 0.05 was not corrected for the large
number of hypothesis tests conducted, leading to a Type 2
error and the acceptance of hypotheses that were likely false
[2].
We counted 37 unique instances in which a p value was
calculated in either the tables or text in the above study. By
the Bonferroni method of correcting for the number of tests
conducted [3], the corrected critical value would be α = 0.05/
37 = 0.00135 instead of α = 0.05. For the less conservative
Šidák correction [3], α = 0.00139. Using either of these
corrected critical values, which is needed to avoid accepting
false hypotheses (Type 2 error) [2], none of the findings in the
study were statistically significant.
Of the findings related to the topic of the study, namely the level
of support for the population-based carrier screening for CF (Table
3 in [1]), the finding that was closest to statistical significance was
the benefit of identification of couples at risk of having a child with
CF (p = 0.004). However, even this finding had a statistical⁎ Corresponding author at: P.O. Box 70658, East Tennessee State University,
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http://dx.doi.org/10.1016/j.jcf.2013.12.005significance that was nearly three times higher than the corrected
critical level for acceptance or rejection (p = 0.00135).
The study [1] had many important strengths, including a
focus on a critical issue for CF families, good sample size, a
well-designed questionnaire, comprehensive statistical analy-
sis, clear written communication, and others. However, due to
the large number of statistical tests conducted without critical
value (α) correction, the conclusions of the study were not
supported by the statistical results. We conclude that it remains
unknown which of the two dozen factors tested in the study, if
any, were associated with the decision to support CF screening
by healthcare professionals.
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